Ibn initiates coverage of oncotelic therapeutics inc.

Austin, texas, sept. 10, 2025 (globe newswire) -- via  ibn – oncotelic therapeutics inc. (otcqb: otlc) , a clinical stage biopharmaceutical company developing transformative oncology and immunotherapy treatments, has selected ibn , a multifaceted financial news and publishing company serving private and public entities, to spearhead its corporate communications efforts.
IBN Ratings Summary
IBN Quant Ranking